AR013478A1 - Metodo para aumentar el volumen oseo. - Google Patents
Metodo para aumentar el volumen oseo.Info
- Publication number
- AR013478A1 AR013478A1 ARP980104480A ARP980104480A AR013478A1 AR 013478 A1 AR013478 A1 AR 013478A1 AR P980104480 A ARP980104480 A AR P980104480A AR P980104480 A ARP980104480 A AR P980104480A AR 013478 A1 AR013478 A1 AR 013478A1
- Authority
- AR
- Argentina
- Prior art keywords
- bone volume
- increase
- prostanoid
- agonist
- pathways
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Métodos novedosos para incrementar el volumen oseo que comprenden activar las vías de cinasa C proteína osteoblástica/calcio intracelular de un sujeto.Además, la invencion se relaciona con un método para tratar y prevenir los trastornos oseosen los cuales la activacion se produce por la admionistracionde un agonista de prostanoide F.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5821897P | 1997-09-09 | 1997-09-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR013478A1 true AR013478A1 (es) | 2000-12-27 |
Family
ID=22015432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980104480A AR013478A1 (es) | 1997-09-09 | 1998-09-08 | Metodo para aumentar el volumen oseo. |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1035853A1 (es) |
JP (1) | JP2001515863A (es) |
CN (1) | CN1269720A (es) |
AR (1) | AR013478A1 (es) |
AU (1) | AU9130298A (es) |
BR (1) | BR9811775A (es) |
CA (1) | CA2303799A1 (es) |
CO (1) | CO5070621A1 (es) |
HU (1) | HUP0003584A3 (es) |
ID (1) | ID24759A (es) |
IL (1) | IL134759A0 (es) |
NO (1) | NO20001172L (es) |
PE (1) | PE118899A1 (es) |
PL (1) | PL339297A1 (es) |
SK (1) | SK3402000A3 (es) |
WO (1) | WO1999012550A1 (es) |
ZA (1) | ZA988229B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1159266B1 (en) * | 1999-03-05 | 2004-11-03 | Duke University | C-16 unsaturated fp-selective prostaglandins analogs |
US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993015767A1 (en) * | 1992-02-05 | 1993-08-19 | Merck & Co., Inc. | Implant therapy for bone growth stimulation |
HN1996000101A (es) * | 1996-02-28 | 1997-06-26 | Inc Pfizer | Terapia combinada para la osteoporosis |
-
1998
- 1998-09-04 HU HU0003584A patent/HUP0003584A3/hu unknown
- 1998-09-04 SK SK340-2000A patent/SK3402000A3/sk unknown
- 1998-09-04 PL PL98339297A patent/PL339297A1/xx unknown
- 1998-09-04 BR BR9811775-0A patent/BR9811775A/pt not_active Application Discontinuation
- 1998-09-04 AU AU91302/98A patent/AU9130298A/en not_active Abandoned
- 1998-09-04 WO PCT/US1998/018337 patent/WO1999012550A1/en not_active Application Discontinuation
- 1998-09-04 CA CA002303799A patent/CA2303799A1/en not_active Abandoned
- 1998-09-04 EP EP98943532A patent/EP1035853A1/en not_active Withdrawn
- 1998-09-04 ID IDW20000638A patent/ID24759A/id unknown
- 1998-09-04 IL IL13475998A patent/IL134759A0/xx unknown
- 1998-09-04 JP JP2000510447A patent/JP2001515863A/ja not_active Withdrawn
- 1998-09-04 CN CN98808884A patent/CN1269720A/zh active Pending
- 1998-09-08 AR ARP980104480A patent/AR013478A1/es not_active Application Discontinuation
- 1998-09-09 CO CO98051809A patent/CO5070621A1/es unknown
- 1998-09-09 PE PE1998000855A patent/PE118899A1/es not_active Application Discontinuation
- 1998-09-09 ZA ZA988229A patent/ZA988229B/xx unknown
-
2000
- 2000-03-07 NO NO20001172A patent/NO20001172L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20001172D0 (no) | 2000-03-07 |
NO20001172L (no) | 2000-05-08 |
PL339297A1 (en) | 2000-12-04 |
JP2001515863A (ja) | 2001-09-25 |
AU9130298A (en) | 1999-03-29 |
HUP0003584A3 (en) | 2002-12-28 |
ZA988229B (en) | 1999-03-09 |
WO1999012550A1 (en) | 1999-03-18 |
PE118899A1 (es) | 2000-02-03 |
ID24759A (id) | 2000-08-03 |
EP1035853A1 (en) | 2000-09-20 |
CA2303799A1 (en) | 1999-03-18 |
BR9811775A (pt) | 2000-08-29 |
SK3402000A3 (en) | 2000-12-11 |
HUP0003584A2 (hu) | 2001-02-28 |
CO5070621A1 (es) | 2001-08-28 |
CN1269720A (zh) | 2000-10-11 |
IL134759A0 (en) | 2001-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR013479A1 (es) | Metodo para aumentar el volumen oseo utilizando agonistas de prostanoide f selectivos no naturales. | |
AR005987A1 (es) | Terapia combinada para la osteoporosis | |
PA8484301A1 (es) | Formulaciones farmaceuticas de liberacion controlada | |
GT199800158AA (es) | Agonistas de prostaglandinas y su uso para tratar trastornos oseos | |
ES2127409T3 (es) | Metodo para la modulacion de la respuesta sexual en el hombre. | |
BR0105457A (pt) | Combinações terapêuticas para estimulação do crescimento ósseo | |
PT777483E (pt) | Metodos e meio para administrar farmacos | |
ES2136624T3 (es) | Implante biocompatible para regular la ovulacion en yeguas. | |
ES2164842T3 (es) | Procedimiento para la preparacion de composiciones de microcapsulas. | |
CY1106160T1 (el) | Mεταβολιτες βουπροπιονης και μεθοδοι συνθεσης και χρησεις τους | |
PA8452701A1 (es) | Agonistas de prostaglandinas | |
BR0113184A (pt) | Implante artificial e processo para produzir o mesmo | |
BR0107942A (pt) | Polìmeros de proteìna de liberação lenta | |
ES2172670T3 (es) | Pirrolpirimidinas y procedimientos para su preparacion. | |
CR7059A (es) | USO DE AGONISTAS INVERSOS DE GABAa EN COMBINACION CON AGONISTAS PARCIALES DEL RECEPTOR DE NICOTINA, ESTROGENOS, MODULADORES SELECTIVOS DE ESTROGENOS O VITAMINA E PARA EL TRAMIENTO DE TRASTORNOS COGNITIVOS | |
AR025883A1 (es) | Utilizacion de antagonistas de los receptores de los cannabinoides centrales para la preparacion de medicamentos | |
DK0998287T3 (da) | Anvendelse af levobupivacain | |
ES2168766T3 (es) | Preparacion farmaceutica que incluye el propeptido vwf. | |
ECSP003707A (es) | Diazepanes | |
BR0011174A (pt) | Composições, compostos, compostos isolados e métodos para controlar pestes | |
BR0209199A (pt) | Controle de campactabilidade através de cristalização | |
AR013478A1 (es) | Metodo para aumentar el volumen oseo. | |
UY26265A1 (es) | Compuestos calciolíticos | |
DK0435177T3 (da) | 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-oner samt deres anvendelse som antikonvulsive midler | |
ES2192874T3 (es) | Proteina c para el tratamiento de la enfermedad de la celula con anemia hepatica y talasemia. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |